Prof. Abdulrahman Al Jazieh

Prof. Abdulrahman Al Jazieh

Prof. Abdulrahman Al Jazieh

Chairman, Oncology Department  KAMS, MNGHA  | KAMS, MNGHA 

Topic: Impacts of delayed diagnosis and treatment on cancer care outcomes

Topic Abstract:

Impact of COVID-19 Pandemic on Cancer Care

Abdul Rahman Jazieh, MD, MPH

Chairman, Oncology Department 


Riyadh, KSA


The COVID-19 pandemic interrupted normal healthcare delivery worldwide leading to various untoward effects on different patients’ populations who are seeking medical care. Cancer patients represent a vulnerable population due to their tendency to contract infection with serious complications from these infections in addition to their need for intense, complicated, and multidisciplinary care that should be delivered on a timely basis.  The risks for cancer patients during the pandemic come from multiple factors including

  1. The risk of infection by the virus and the worse outcome among cancer patients when they contract the infection.


  1. The interruption of cancer care and delay in the delivery of timely care, which will negatively impact the outcome.


  • The interruption of other medical care for other diseases and comorbidities, which are common among cancer patients.


  • Delay in the diagnosis and screening and early detection of cancer 


  • Interruption of cancer control prevention activities.


The health care delivery has adapted to the COVID-19 pandemic with many interventions including virtual care and remote and near-home delivery of care for cancer patients.  The new normal of cancer care delivery is going to be different than the pre-pandemic care incorporating the modification to healthcare delivery in a positive way.  Nevertheless, the negative impact on cancer patient’s outcomes may last for a few years beyond the pandemic and requires a systemic approach to mitigate this negative impact as early as possible. 


My main goal is to improve cancer care across borders through capacity building, professional development and training, facilitating collaboration, adopting innovations, encouraging research, and enhancing evidence-based, safe, and multidisciplinary care for cancer patients.

Cincinnati Cancer Advisors
September 2020 – Present (3 months)
Cincinnati, Ohio, United States

Global Journal on Quality and Safety in Healthcare
Editor In Chief
November 2017 – Present (3 years 1 month)
Cincinnati, Ohio


University of Cincinnati
Advisor on Oncology Quality Care and Patient Safety at UC Cancer Institute
September 2017 – Present (3 years 3 months)
Cincinnati, Ohio

Oncology Department, National Guard Health Affairs
January 2006 – Present (14 years 11 months)
Riyadh, KSA
Quality Improvement

Professional Development
Clinical Care for Cancer Patients
Clinical Research
Multidisciplinary Teams Building


American Society of Clinical Oncology (ASCO)
Chairman, International Affairs Committee
June 2018 – June 2019 (1 year 1 month)

University of Cincinnati
Professor and Head, Division of Hematology and Oncology
July 2000 – January 2006 (5 years 7 months)
Cincinnati, OH

Overseeing all the activities of the division in all aspects including clinical care,
research, academic work, administrative, and business.
The University of Arkansas For Medical Sciences
Assistant Professor of Medicine, Division of Hematology and Oncology
July 1996 – July 2000 (4 years 1 month)
Little Rock, AR